Stock Chart
MNKD
Type: SELL wallstreet
Strike: $7
Premium: $1.10
Expiry: Jan 15, 2027
Target: $8
Score: -55
LEAPs are long-term options (1+ year) with less time decay.
Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech
Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity
Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
About MNKD - Mannkind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.
Key Statistics
More MNKD Analysis
This MNKD stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MNKD's price movements with trendlines, gamma walls, and key support/resistance levels.